The Association Between α1-Antitrypsin and Coronary Artery Ectasia
Fatma Nihan Turhan Caglar1, Vusal Ksanski1, Veli Polat1
11 Cardiology Department, Bakirkoy Dr. Sadi Konuk Education and Research Hospital, Istanbul, Turkey.
Insights
Lower serum alpha-1 antitrypsin (A1AT) levels are linked to coronary artery ectasia (CAE). This suggests A1AT deficiency may contribute to arterial wall weakening and ectasia formation in patients with this condition.
Area of Science:
- Cardiology
- Biochemistry
- Genetics
Background:
- Coronary artery ectasia (CAE) is a condition associated with coronary artery disease, but its pathophysiology remains unclear.
- Alpha-1 antitrypsin (A1AT) is crucial in regulating protease activity, and A1AT deficiency (A1ATD) is linked to coronary artery disease.
- Understanding factors contributing to CAE is vital for cardiovascular health management.
Purpose of the Study:
- To investigate the association between serum A1AT levels and the presence of isolated CAE.
- To determine if A1AT levels correlate with the extent of ectasia in patients with CAE.
Main Methods:
- Serum A1AT levels were measured in 50 patients with isolated CAE and 46 controls using nephelometry.
- Patients underwent coronary angiography, and CAE extent was assessed using the Markis score.
- Statistical analysis compared A1AT levels between groups and correlated them with the Markis score.
Main Results:
- Median A1AT levels were significantly lower in patients with isolated CAE compared to controls (P < .001).
- No significant correlation was found between A1AT serum levels and the extent of CAE as determined by the Markis score (P = .41).
Conclusions:
- Serum A1AT levels are inversely associated with the presence of coronary artery ectasia.
- Reduced A1AT may compromise arterial wall integrity by impairing protease inhibition, potentially contributing to ectasia development.
Abstract:
Coronary artery ectasia (CAE) is associated with coronary artery disease (CAD). The underlying pathophysiology of CAE is not fully understood. α1-antitrypsin (A1AT) plays a role in the tissue protease system, and AAT-1 deficiency (A1ATD) has been shown to be related to CAD. We compared A1AT serum levels in patients with and without CAE to determine the association between A1AT levels and the extent of ectasia using the Markis score. We included 50 patients (38 males) with isolated CAE and 46 patients (28 males) with normal coronary arteries after coronary angiography. The levels of A1AT were measured by nephelometry. The median A1AT levels were lower in patients with isolated CAE than in the control group (1.27 ng/mL [range: 1.07-1.37 ng/mL] vs 1.43 ng/mL [range: 1.27-1.59 ng/mL]; P < .001). According to the Markis classification, the extent of CAE was not correlated with A1AT levels ( P = .41). Our results demonstrate an inverse relationship between serum A1AT levels and CAE. α1-antitrypsin is fundamental for the stability and integrity of the arterial wall. Lack of elastase inhibition in cases of A1ATD may contribute to ectasia formation by facilitating proteolysis and weakening the arterial wall.
More Related Videos
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests


